Turalio and Panic attack - a phase IV clinical study of FDA data

Summary:

Panic attack is reported as a side effect among people who take Turalio (pexidartinib hydrochloride), especially for people who are female, 50-59 old, also take Estradiol, and have Synovitis.

The phase IV clinical study analyzes which people have Panic attack when taking Turalio. It is created by eHealthMe based on reports of 1,355 people who have side effects when taking Turalio from the FDA, and is updated regularly.

What is Turalio?

Turalio has active ingredients of pexidartinib hydrochloride. eHealthMe is studying from 1,355 Turalio users. Check the latest studies of Turalio.

What is Panic attack?

Panic attack is found to be associated with 2,356 drugs and 2,081 conditions by eHealthMe. Check the latest studies of Panic attack.

On Jun, 26, 2026

1,355 people reported to have side effects when taking Turalio.
Among them, 11 people (0.81%) have Panic attack.

Among these 11 people:

What is the gender of people who have Panic attack when taking Turalio? *

female: 100 %
male: 0.0 %

What is the age of people who have Panic attack when taking Turalio? *

What are other drugs people take besides Turalio? *

What are other side effects people have besides Panic attack? *

Hair Color Changes: 10 people, 90.91%
Nausea (feeling of having an urge to vomit): 10 people, 90.91%
Stress And Anxiety: 9 people, 81.82%
Feeling Abnormal: 8 people, 72.73%
Pain: 7 people, 63.64%
Abdominal Pain Upper: 7 people, 63.64%
Headache (pain in head): 7 people, 63.64%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 7 people, 63.64%
Insomnia (sleeplessness): 7 people, 63.64%
Photophobia (extreme sensitivity to light): 6 people, 54.55%

What are the existing conditions these people have? *

Synovitis (inflammation of the synovial membrane): 8 people, 72.73%
Giant Cell Tumor Of Tendon Sheath: 7 people, 63.64%
Tenosynovitis (inflammation of the fluid-filled sheath (called the synovium) that surrounds a tendon): 3 people, 27.27%
Tumor: 1 person, 9.09%
Soft Tissue Neoplasm (tumour of soft tissue): 1 person, 9.09%
Menopause (end of monthly cycles in women): 1 person, 9.09%
Connective Tissue Neoplasm (tumour of connective tissue): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Turalio and have Panic attack?

- Check whether Panic attack is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Turalio:

Turalio (1,355 reports)

Panic attack treatments and more:

Panic attack (65,704 reports)

Browse all side effects of Turalio:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Panic attack:

Panic attack (2,356 drugs)

Browse all the conditions that are associated with Panic attack:

Panic attack (2,081 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pexidartinib hydrochloride (the active ingredients of Turalio) and Turalio (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.